» Articles » PMID: 23861667

Alu Elements in ANRIL Non-coding RNA at Chromosome 9p21 Modulate Atherogenic Cell Functions Through Trans-regulation of Gene Networks

Abstract

The chromosome 9p21 (Chr9p21) locus of coronary artery disease has been identified in the first surge of genome-wide association and is the strongest genetic factor of atherosclerosis known today. Chr9p21 encodes the long non-coding RNA (ncRNA) antisense non-coding RNA in the INK4 locus (ANRIL). ANRIL expression is associated with the Chr9p21 genotype and correlated with atherosclerosis severity. Here, we report on the molecular mechanisms through which ANRIL regulates target-genes in trans, leading to increased cell proliferation, increased cell adhesion and decreased apoptosis, which are all essential mechanisms of atherogenesis. Importantly, trans-regulation was dependent on Alu motifs, which marked the promoters of ANRIL target genes and were mirrored in ANRIL RNA transcripts. ANRIL bound Polycomb group proteins that were highly enriched in the proximity of Alu motifs across the genome and were recruited to promoters of target genes upon ANRIL over-expression. The functional relevance of Alu motifs in ANRIL was confirmed by deletion and mutagenesis, reversing trans-regulation and atherogenic cell functions. ANRIL-regulated networks were confirmed in 2280 individuals with and without coronary artery disease and functionally validated in primary cells from patients carrying the Chr9p21 risk allele. Our study provides a molecular mechanism for pro-atherogenic effects of ANRIL at Chr9p21 and suggests a novel role for Alu elements in epigenetic gene regulation by long ncRNAs.

Citing Articles

Endometriosis and risk of cardiovascular disease: a systematic review and meta-analysis.

Parsa S, Noroozpoor R, Dehghanbanadaki H, Khateri S, Moradi Y BMC Public Health. 2025; 25(1):245.

PMID: 39833762 PMC: 11748313. DOI: 10.1186/s12889-025-21486-0.


Six genetic variants are associated with cardiovascular disease independently from canonical risk factors: a new method to refine GWAS results based on the UKBiobank phenotype database.

Noto D, Gagliardo C, Spina R, Giammanco A, Ciaccio M, Cefalu A Mol Genet Genomics. 2024; 300(1):4.

PMID: 39704901 DOI: 10.1007/s00438-024-02202-w.


Progress and trends in myocardial infarction-related long non-coding RNAs: a bibliometric analysis.

Meng Q, Tan H, Wang C, Sun Z Front Mol Biosci. 2024; 11:1382772.

PMID: 39135912 PMC: 11317247. DOI: 10.3389/fmolb.2024.1382772.


LncRNAs are involved in regulating ageing and age-related disease through the adenosine monophosphate-activated protein kinase signalling pathway.

Li J, Xiao F, Wang S, Fan X, He Z, Yan T Genes Dis. 2024; 11(5):101042.

PMID: 38966041 PMC: 11222807. DOI: 10.1016/j.gendis.2023.06.014.


The 9p21.3 coronary artery disease risk locus drives vascular smooth muscle cells to an osteochondrogenic state.

Salido E, de Medeiros Vieira C, Mosquera J, Zade R, Parikh P, Suryavanshi S bioRxiv. 2024; .

PMID: 38853913 PMC: 11160673. DOI: 10.1101/2024.05.25.595888.


References
1.
Shin H, Liu T, Manrai A, Liu X . CEAS: cis-regulatory element annotation system. Bioinformatics. 2009; 25(19):2605-6. DOI: 10.1093/bioinformatics/btp479. View

2.
Amaral P, Mattick J . Noncoding RNA in development. Mamm Genome. 2008; 19(7-8):454-92. DOI: 10.1007/s00335-008-9136-7. View

3.
Bracken A, Helin K . Polycomb group proteins: navigators of lineage pathways led astray in cancer. Nat Rev Cancer. 2009; 9(11):773-84. DOI: 10.1038/nrc2736. View

4.
Cowley M, Oakey R . Transposable elements re-wire and fine-tune the transcriptome. PLoS Genet. 2013; 9(1):e1003234. PMC: 3554611. DOI: 10.1371/journal.pgen.1003234. View

5.
Chu C, Qu K, Zhong F, Artandi S, Chang H . Genomic maps of long noncoding RNA occupancy reveal principles of RNA-chromatin interactions. Mol Cell. 2011; 44(4):667-78. PMC: 3249421. DOI: 10.1016/j.molcel.2011.08.027. View